Chinese- REPORT SUMMARY
- TABLE OF CONTENTS
-
Anti-diabetic drug refers to the medications consumed orally that are prescribed to treat diabetes mellitus (type 2). It treats diabetes (type 2) by lowering down the blood sugar level. These are also known as oral hypoglycemic agents or oral antihyperglycemic agents. Oral anti-diabetic drugs are often prescribed as monotherapy but in severe cases, can be given in combination with insulin.
This report elaborates on the current development of the Oral Anti-Diabetic Drug industry thoroughly based on the international market dynamics and China's market situation.
For a start, the report provides an in-depth analysis of the current market situation through three different aspects - by region, by type and by application, which includes market distribution of different types and applications, import and export analysis of major regions, development trends of different types of products in each region, market opportunities and market restrains of different applications.
Secondly, this report lists the major players in the industry, displaying their market positions and strengths and weaknesses of their products, picturing the current competitive situation of the whole market.
Last but not least, the report analyzes and predicts the investment prospects and risks in the industry on the basis of industry data, combined with experts' opinions and suggestions.
By Player:
Merck And Co
Novartis
Abbott
Sanofi
AstraZeneca
Boehringer Ingelheim
Janssen Pharmaceuticals
Takeda
Biocon
Bristol Myers Squibb
Pfizer
By Type:
Glimepiride
Others
Glyburide
Gliclazide
By Application:
Hospital
Research Institual
By Research Region:
-
North China
-
Central China
-
South China
-
East China
-
Northeast China
-
Southwest China
-
Northwest China
TABLE OF CONTENT
Chapter 1 China Oral Anti-Diabetic Drug Market Overview 2018-2029
-
1.1 China Oral Anti-Diabetic Drug Industry Development Overview
-
1.2 China Oral Anti-Diabetic Drug Industry Development History
-
1.3 China Oral Anti-Diabetic Drug Industry Market Size (2018-2029)
-
1.4 China Oral Anti-Diabetic Drug Market Analysis by Type from Production Side
-
1.4.1 China Oral Anti-Diabetic Drug Production Volume, Production Value and Growth Rate of Glimepiride (2018-2029)
-
1.4.2 China Oral Anti-Diabetic Drug Production Volume, Production Value and Growth Rate of Others (2018-2029)
-
1.4.3 China Oral Anti-Diabetic Drug Production Volume, Production Value and Growth Rate of Glyburide (2018-2029)
-
1.4.4 China Oral Anti-Diabetic Drug Production Volume, Production Value and Growth Rate of Gliclazide (2018-2029)
-
1.5 China Oral Anti-Diabetic Drug Market Analysis by Application from Consumption End
-
1.5.1 China Oral Anti-Diabetic Drug Sales Volume, Sales Value and Growth Rate of Hospital (2018-2029)
-
1.5.2 China Oral Anti-Diabetic Drug Sales Volume, Sales Value and Growth Rate of Research Institual (2018-2029)
-
1.6 China Oral Anti-Diabetic Drug Market Analysis by Region
-
1.6.1 North China Oral Anti-Diabetic Drug Market Size and Growth Rate from 2018-2029
-
1.6.2 Central China Oral Anti-Diabetic Drug Market Size and Growth Rate from 2018-2029
-
1.6.3 South China Oral Anti-Diabetic Drug Market Size and Growth Rate from 2018-2029
-
1.6.4 East China Oral Anti-Diabetic Drug Market Size and Growth Rate from 2018-2029
-
1.6.5 Northeast China Oral Anti-Diabetic Drug Market Size and Growth Rate from 2018-2029
-
1.6.6 Southwest China Oral Anti-Diabetic Drug Market Size and Growth Rate from 2018-2029
-
1.6.7 Northwest China Oral Anti-Diabetic Drug Market Size and Growth Rate from 2018-2029
Chapter 2 China Oral Anti-Diabetic Drug Industry Development Environment
-
2.1 Industry Development Environment Analysis
-
2.1.1 Industry Technological Progress Analysis
-
2.1.2 Industrial Organizational Innovation Analysis
-
2.1.3 Changes in Social Habits
-
2.1.4 Alterations in Government Policies
-
2.1.5 Impact of Economic Globalization
-
2.2 Domestic and Foreign Industry Competition Analysis
-
2.2.1 Comparative Analysis on Oral Anti-Diabetic Drug Market Status and Competition at home and abroad in 2023
-
2.2.2 China Oral Anti-Diabetic Drug Market Status and Competition Analysis in 2023
-
2.2.3 China Oral Anti-Diabetic Drug Market Concentration Analysis in 2023
-
2.3 Problems and Countermeasures in the development of China Oral Anti-Diabetic Drug Industry
-
2.3.1 Industry Development Constraints
-
2.3.2 Industry Development Considerations
-
2.3.3 Suggestions on Industry Development Measures
-
2.3.4 Development Strategies for SMEs
-
2.4 Influence of COVID-19 Outbreak on Oral Anti-Diabetic Drug Industry Development
Chapter 3 Oral Anti-Diabetic DrugIndustry Chain Analysis
-
3.1 Oral Anti-Diabetic Drug Industry Chain
-
3.2 Oral Anti-Diabetic Drug Upstream Industry Analysis
-
3.2.1 Upstream Industry Development Status
-
3.2.2 Upstream Industry Development Forecast
-
3.2.3 Impact of Upstream Industry on the Oral Anti-Diabetic Drug Market
-
3.3 Oral Anti-Diabetic Drug Downstream Industry Analysis
-
3.3.1 Downstream Industry Development Status
-
3.3.2 Downstream Industry Development Forecast
-
3.3.3 Impact of Downstream Industry on the Oral Anti-Diabetic Drug Market
Chapter 4 China Oral Anti-Diabetic Drug Market, by Type
-
4.1 China Oral Anti-Diabetic Drug Market Trend, by Type
-
4.2 Product Types of Major Suppliers
-
4.3 Competitive Landscape of Major Types
-
4.4 China Oral Anti-Diabetic Drug Total Production Volume and Growth Rate from Production Side
-
4.5 China Oral Anti-Diabetic Drug Production Volume and Growth Rate, by Type
-
4.5.1 China Oral Anti-Diabetic Drug Production Volume and Growth Rate of Glimepiride
-
4.5.2 China Oral Anti-Diabetic Drug Production Volume and Growth Rate of Others
-
4.5.3 China Oral Anti-Diabetic Drug Production Volume and Growth Rate of Glyburide
-
4.5.4 China Oral Anti-Diabetic Drug Production Volume and Growth Rate of Gliclazide
Chapter 5 China Oral Anti-Diabetic Drug Market, by Application
-
5.1 Downstream Market Overview
-
5.2 Competitive Landscape of Major Applications
-
5.3 Market Potential Analysis, by Application
-
5.4 China Oral Anti-Diabetic Drug Total Market Size and Growth Rate from Consumption End
-
5.5 China Oral Anti-Diabetic Drug Market Size and Growth Rate, by Application
-
5.5.1 China Oral Anti-Diabetic Drug Market Size and Growth Rate of Hospital
-
5.5.2 China Oral Anti-Diabetic Drug Market Size and Growth Rate of Research Institual
Chapter 6 China Oral Anti-Diabetic Drug Market, by Region
-
6.1 China Oral Anti-Diabetic Drug Production Volume and Production Value, by Region
-
6.2 China Oral Anti-Diabetic Drug Sales Volume and Sales Value, by Region
Chapter 7 North China Oral Anti-Diabetic Drug Market Analysis
-
7.1 North China Oral Anti-Diabetic Drug Market, by Type
-
7.2 North China Oral Anti-Diabetic Drug Market, by Application
Chapter 8 Central China Oral Anti-Diabetic Drug Market Analysis
-
8.1 Central China Oral Anti-Diabetic Drug Market, by Type
-
8.2 Central China Oral Anti-Diabetic Drug Market, by Application
Chapter 9 South China Oral Anti-Diabetic Drug Market Analysis
-
9.1 South China Oral Anti-Diabetic Drug Market, by Type
-
9.2 South China Oral Anti-Diabetic Drug Market, by Application
Chapter 10 East China Oral Anti-Diabetic Drug Market Analysis
-
10.1 East China Oral Anti-Diabetic Drug Market, by Type
-
10.2 East China Oral Anti-Diabetic Drug Market, by Application
Chapter 11 Northeast China Oral Anti-Diabetic Drug Market Analysis
-
11.1 Northeast China Oral Anti-Diabetic Drug Market, by Type
-
11.2 Northeast China Oral Anti-Diabetic Drug Market, by Application
Chapter 12 Southwest China Oral Anti-Diabetic Drug Market Analysis
-
12.1 Southwest China Oral Anti-Diabetic Drug Market, by Type
-
12.2 Southwest China Oral Anti-Diabetic Drug Market, by Application
Chapter 13 Northwest China Oral Anti-Diabetic Drug Market Analysis
-
13.1 Northwest China Oral Anti-Diabetic Drug Market, by Type
-
13.2 Northwest China Oral Anti-Diabetic Drug Market, by Application
Chapter 14 Company Profiles
-
14.1 Merck And Co
-
14.1.1 Merck And Co Company Profile
-
14.1.2 Merck And Co Oral Anti-Diabetic Drug Market Performance
-
14.1.3 Product&Service Introduction
-
14.2 Novartis
-
14.2.1 Novartis Company Profile
-
14.2.2 Novartis Oral Anti-Diabetic Drug Market Performance
-
14.2.3 Product&Service Introduction
-
14.3 Abbott
-
14.3.1 Abbott Company Profile
-
14.3.2 Abbott Oral Anti-Diabetic Drug Market Performance
-
14.3.3 Product&Service Introduction
-
14.4 Sanofi
-
14.4.1 Sanofi Company Profile
-
14.4.2 Sanofi Oral Anti-Diabetic Drug Market Performance
-
14.4.3 Product&Service Introduction
-
14.5 AstraZeneca
-
14.5.1 AstraZeneca Company Profile
-
14.5.2 AstraZeneca Oral Anti-Diabetic Drug Market Performance
-
14.5.3 Product&Service Introduction
-
14.6 Boehringer Ingelheim
-
14.6.1 Boehringer Ingelheim Company Profile
-
14.6.2 Boehringer Ingelheim Oral Anti-Diabetic Drug Market Performance
-
14.6.3 Product&Service Introduction
-
14.7 Janssen Pharmaceuticals
-
14.7.1 Janssen Pharmaceuticals Company Profile
-
14.7.2 Janssen Pharmaceuticals Oral Anti-Diabetic Drug Market Performance
-
14.7.3 Product&Service Introduction
-
14.8 Takeda
-
14.8.1 Takeda Company Profile
-
14.8.2 Takeda Oral Anti-Diabetic Drug Market Performance
-
14.8.3 Product&Service Introduction
-
14.9 Biocon
-
14.9.1 Biocon Company Profile
-
14.9.2 Biocon Oral Anti-Diabetic Drug Market Performance
-
14.9.3 Product&Service Introduction
-
14.10 Bristol Myers Squibb
-
14.10.1 Bristol Myers Squibb Company Profile
-
14.10.2 Bristol Myers Squibb Oral Anti-Diabetic Drug Market Performance
-
14.10.3 Product&Service Introduction
-
14.11 Pfizer
-
14.11.1 Pfizer Company Profile
-
14.11.2 Pfizer Oral Anti-Diabetic Drug Market Performance
-
14.11.3 Product&Service Introduction
Chapter 15 Research Conclusions and Investment Suggestions
-
15.1 Oral Anti-Diabetic Drug Industry Research Conclusions
-
15.2 Oral Anti-Diabetic Drug Industry Investment Suggestions
-
15.2.1 Suggestions on Industry Development Strategy
-
15.2.2 Suggestions on Industry Investment Direction
-
15.2.3 Suggestions on Industry Investment Strategy
List of Tables and Figures
-
Figure China Oral Anti-Diabetic Drug Industry Market Size (2018-2029)
-
Figure China Oral Anti-Diabetic Drug Production Volume, Production Value and Growth Rate of Glimepiride (2018-2029)
-
Figure China Oral Anti-Diabetic Drug Production Volume, Production Value and Growth Rate of Others (2018-2029)
-
Figure China Oral Anti-Diabetic Drug Production Volume, Production Value and Growth Rate of Glyburide (2018-2029)
-
Figure China Oral Anti-Diabetic Drug Production Volume, Production Value and Growth Rate of Gliclazide (2018-2029)
-
Figure China Oral Anti-Diabetic Drug Sales Volume, Sales Value and Growth Rate of Hospital (2018-2029)
-
Figure China Oral Anti-Diabetic Drug Sales Volume, Sales Value and Growth Rate of Research Institual (2018-2029)
-
Figure North China Oral Anti-Diabetic Drug Market Size and Growth Rate from 2018-2029
-
Figure Central China Oral Anti-Diabetic Drug Market Size and Growth Rate from 2018-2029
-
Figure South China Oral Anti-Diabetic Drug Market Size and Growth Rate from 2018-2029
-
Figure East China Oral Anti-Diabetic Drug Market Size and Growth Rate from 2018-2029
-
Figure Northeast China Oral Anti-Diabetic Drug Market Size and Growth Rate from 2018-2029
-
Figure Southwest China Oral Anti-Diabetic Drug Market Size and Growth Rate from 2018-2029
-
Figure Northwest China Oral Anti-Diabetic Drug Market Size and Growth Rate from 2018-2029
-
Figure Oral Anti-Diabetic Drug Industry Chain
-
Table Product Types of Major Suppliers in 2023
-
Figure China Oral Anti-Diabetic Drug Market Share by Type in 2018
-
Figure China Oral Anti-Diabetic Drug Market Share by Type in 2023
-
Figure China Oral Anti-Diabetic Drug Total Production Volume and Growth Rate from Production Side (2018-2023)
-
Figure China Oral Anti-Diabetic Drug Production Volume and Growth Rate of Glimepiride (2018-2023)
-
Figure China Oral Anti-Diabetic Drug Production Volume and Growth Rate of Others (2018-2023)
-
Figure China Oral Anti-Diabetic Drug Production Volume and Growth Rate of Glyburide (2018-2023)
-
Figure China Oral Anti-Diabetic Drug Production Volume and Growth Rate of Gliclazide (2018-2023)
-
Figure China Oral Anti-Diabetic Drug Market Share by Application in 2018
-
Figure China Oral Anti-Diabetic Drug Market Share by Application in 2023
-
Figure China Oral Anti-Diabetic Drug Total Market Size and Growth Rate from Consumption End
-
Figure China Oral Anti-Diabetic Drug Market Size and Growth Rate of Hospital (2018-2023)
-
Figure China Oral Anti-Diabetic Drug Market Size and Growth Rate of Research Institual (2018-2023)
-
Table China Oral Anti-Diabetic Drug Production Volume by Region (2018-2023)
-
Table China Oral Anti-Diabetic Drug Production Volume Share by Region (2018-2023)
-
Figure China Oral Anti-Diabetic Drug Production Volume Share by Region (2018-2023)
-
Table China Oral Anti-Diabetic Drug Production Value by Region (2018-2023)
-
Table China Oral Anti-Diabetic Drug Production Value Share by Region (2018-2023)
-
Figure China Oral Anti-Diabetic Drug Production Value Share by Region (2018-2023)
-
Table China Oral Anti-Diabetic Drug Sales Volume by Region (2018-2023)
-
Table China Oral Anti-Diabetic Drug Sales Volume Share by Region (2018-2023)
-
Figure China Oral Anti-Diabetic Drug Sales Volume Share by Region (2018-2023)
-
Table China Oral Anti-Diabetic Drug Sales Value by Region (2018-2023)
-
Table China Oral Anti-Diabetic Drug Sales Value Share by Region (2018-2023)
-
Figure China Oral Anti-Diabetic Drug Sales Value Share by Region (2018-2023)
-
Table North China Oral Anti-Diabetic Drug Production Volume by Type (2018-2023)
-
Table North China Oral Anti-Diabetic Drug Production Volume Share by Type (2018-2023)
-
Figure North China Oral Anti-Diabetic Drug Production Volume Share by Type (2018-2023)
-
Table North China Oral Anti-Diabetic Drug Sales Volume by Application (2018-2023)
-
Table North China Oral Anti-Diabetic Drug Sales Volume Share by Application (2018-2023)
-
Figure North China Oral Anti-Diabetic Drug Sales Volume Share by Application (2018-2023)
-
Table Central China Oral Anti-Diabetic Drug Production Volume by Type (2018-2023)
-
Table Central China Oral Anti-Diabetic Drug Production Volume Share by Type (2018-2023)
-
Figure Central China Oral Anti-Diabetic Drug Production Volume Share by Type (2018-2023)
-
Table Central China Oral Anti-Diabetic Drug Sales Volume by Application (2018-2023)
-
Table Central China Oral Anti-Diabetic Drug Sales Volume Share by Application (2018-2023)
-
Figure Central China Oral Anti-Diabetic Drug Sales Volume Share by Application (2018-2023)
-
Table South China Oral Anti-Diabetic Drug Production Volume by Type (2018-2023)
-
Table South China Oral Anti-Diabetic Drug Production Volume Share by Type (2018-2023)
-
Figure South China Oral Anti-Diabetic Drug Production Volume Share by Type (2018-2023)
-
Table South China Oral Anti-Diabetic Drug Sales Volume by Application (2018-2023)
-
Table South China Oral Anti-Diabetic Drug Sales Volume Share by Application (2018-2023)
-
Figure South China Oral Anti-Diabetic Drug Sales Volume Share by Application (2018-2023)
-
Table East China Oral Anti-Diabetic Drug Production Volume by Type (2018-2023)
-
Table East China Oral Anti-Diabetic Drug Production Volume Share by Type (2018-2023)
-
Figure East China Oral Anti-Diabetic Drug Production Volume Share by Type (2018-2023)
-
Table East China Oral Anti-Diabetic Drug Sales Volume by Application (2018-2023)
-
Table East China Oral Anti-Diabetic Drug Sales Volume Share by Application (2018-2023)
-
Figure East China Oral Anti-Diabetic Drug Sales Volume Share by Application (2018-2023)
-
Table Northeast China Oral Anti-Diabetic Drug Production Volume by Type (2018-2023)
-
Table Northeast China Oral Anti-Diabetic Drug Production Volume Share by Type (2018-2023)
-
Figure Northeast China Oral Anti-Diabetic Drug Production Volume Share by Type (2018-2023)
-
Table Northeast China Oral Anti-Diabetic Drug Sales Volume by Application (2018-2023)
-
Table Northeast China Oral Anti-Diabetic Drug Sales Volume Share by Application (2018-2023)
-
Figure Northeast China Oral Anti-Diabetic Drug Sales Volume Share by Application (2018-2023)
-
Table Southwest China Oral Anti-Diabetic Drug Production Volume by Type (2018-2023)
-
Table Southwest China Oral Anti-Diabetic Drug Production Volume Share by Type (2018-2023)
-
Figure Southwest China Oral Anti-Diabetic Drug Production Volume Share by Type (2018-2023)
-
Table Southwest China Oral Anti-Diabetic Drug Sales Volume by Application (2018-2023)
-
Table Southwest China Oral Anti-Diabetic Drug Sales Volume Share by Application (2018-2023)
-
Figure Southwest China Oral Anti-Diabetic Drug Sales Volume Share by Application (2018-2023)
-
Table Northwest China Oral Anti-Diabetic Drug Production Volume by Type (2018-2023)
-
Table Northwest China Oral Anti-Diabetic Drug Production Volume Share by Type (2018-2023)
-
Figure Northwest China Oral Anti-Diabetic Drug Production Volume Share by Type (2018-2023)
-
Table Northwest China Oral Anti-Diabetic Drug Sales Volume by Application (2018-2023)
-
Table Northwest China Oral Anti-Diabetic Drug Sales Volume Share by Application (2018-2023)
-
Figure Northwest China Oral Anti-Diabetic Drug Sales Volume Share by Application (2018-2023)
-
Table Merck And Co Company Profile
-
Table Merck And Co Oral Anti-Diabetic Drug Revenue, Price and Gross (2018-2023)
-
Table Novartis Company Profile
-
Table Novartis Oral Anti-Diabetic Drug Revenue, Price and Gross (2018-2023)
-
Table Abbott Company Profile
-
Table Abbott Oral Anti-Diabetic Drug Revenue, Price and Gross (2018-2023)
-
Table Sanofi Company Profile
-
Table Sanofi Oral Anti-Diabetic Drug Revenue, Price and Gross (2018-2023)
-
Table AstraZeneca Company Profile
-
Table AstraZeneca Oral Anti-Diabetic Drug Revenue, Price and Gross (2018-2023)
-
Table Boehringer Ingelheim Company Profile
-
Table Boehringer Ingelheim Oral Anti-Diabetic Drug Revenue, Price and Gross (2018-2023)
-
Table Janssen Pharmaceuticals Company Profile
-
Table Janssen Pharmaceuticals Oral Anti-Diabetic Drug Revenue, Price and Gross (2018-2023)
-
Table Takeda Company Profile
-
Table Takeda Oral Anti-Diabetic Drug Revenue, Price and Gross (2018-2023)
-
Table Biocon Company Profile
-
Table Biocon Oral Anti-Diabetic Drug Revenue, Price and Gross (2018-2023)
-
Table Bristol Myers Squibb Company Profile
-
Table Bristol Myers Squibb Oral Anti-Diabetic Drug Revenue, Price and Gross (2018-2023)
-
Table Pfizer Company Profile
-
Table Pfizer Oral Anti-Diabetic Drug Revenue, Price and Gross (2018-2023)
-
